MRI features of combined hepatocellular-cholangiocarcinoma

被引:0
|
作者
Majeed, Noor Fatima [1 ]
Macey, Mathew [2 ]
Amirfarzan, Marta Braschi [3 ]
Sharifi, Sheida [2 ]
Wortman, Jeremy R. [2 ]
机构
[1] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30307 USA
[2] Lahey Hosp & Med Ctr, Dept Radiol, Burlington, MA USA
[3] Lahey Hosp & Med Ctr, Dept Pathol, Burlington, MA USA
关键词
Combined hepatocellular cholangiocarcinoma; Mixed hepatocellular cholangiocarcinoma; Cholangiohepatoma; Hepatocholangiocarcinoma; CARCINOMA;
D O I
10.1007/s00261-024-04476-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare liver tumor which has a more aggressive behavior and worse survival outcome than hepatocellular carcinoma (HCC), with a prognosis similar to that of intrahepatic cholangiocarcinoma (iCCA). With limited literature on the appearance of this tumor on MRI, it remains a diagnostic challenge. In this review, we looked at the currently described MRI findings in this uncommon entity. Based on studies conducted to date, a mixed pattern at imaging has demonstrated the highest specificity, seen as a combination of areas showing progressive enhancement of the lesion, arterial enhancement with washout, and areas of arterial enhancement without washout and/or hypovascularity. Tumor markers may aid in identification, particularly in cases where the imaging appearance mimics that of isolated HCC or iCCA. Intratumoral heterogeneity leads to difficulties with pathologic diagnosis from sampling due to the possibility of an incorrect diagnosis if the biopsy specimen does not contain adequate tissue comprising both histologic components.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 50 条
  • [31] EXPRESSION OF ABH AND LEWIS BLOOD-GROUP ANTIGENS IN COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA - POSSIBLE EVIDENCE FOR THE HEPATOCELLULAR ORIGIN OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    OKADA, Y
    JINNO, K
    MORIWAKI, S
    MORICHIKA, S
    TORIGOE, SI
    ARIMA, T
    NAGASHIMA, H
    KOPROWSKI, H
    CANCER, 1987, 60 (03) : 345 - 352
  • [32] The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value
    Ruofan Sheng
    Chun Yang
    Yunfei Zhang
    Heqing Wang
    Beixuan Zheng
    Jing Han
    Wei Sun
    Mengsu Zeng
    La radiologia medica, 2023, 128 : 1047 - 1060
  • [33] Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers
    Wakizaka, Kazuki
    Yokoo, Hideki
    Kamiyama, Toshiya
    Ohira, Masafumi
    Kato, Koichi
    Fujii, Yuki
    Sugiyama, Ko
    Okada, Naoki
    Ohata, Takanori
    Nagatsu, Akihisa
    Shimada, Shingo
    Orimo, Tatsuya
    Kamachi, Hirofumi
    Taketomi, Akinobu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (06) : 1074 - 1080
  • [34] Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki, M.
    Sato, Y.
    Nakanuma, Y.
    HISTOPATHOLOGY, 2022, 80 (05) : 859 - 868
  • [35] A HISTOCHEMICAL-STUDY ON COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    UEKUSA, T
    MASTUMOTO, T
    ABE, H
    FUKUDA, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1985, 18 (06) : 673 - 673
  • [36] A HISTOCHEMICAL-STUDY ON COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    UEKUSA, T
    MASTUMOTO, T
    ABE, H
    FUKUDA, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1987, 20 (06) : 737 - 737
  • [37] Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection
    Chi, Chen-Ta
    Chau, Gar-Yang
    Lee, Rheun-Chuan
    Chen, Yen-Ying
    Lei, Hao-Jan
    Hou, Ming-Chih
    Chao, Yee
    Huang, Yi-Hsiang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 125 - 133
  • [38] Epigenetic regulation of combined hepatocellular-cholangiocarcinoma subtypes
    Schachtschneider, Kyle M.
    Lokken, Ryan Peter
    Huang, Yu-Hui
    Guzman, Grace
    Schook, Lawrence B.
    Gaba, Ron C.
    CANCER RESEARCH, 2019, 79 (13)
  • [39] COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA - A HISTOLOGIC AND IMMMUNOHISTOCHEMICAL STUDY
    GOODMAN, ZD
    ISHAK, KG
    LANGLOSS, JM
    SESTERHENN, IA
    RABIN, L
    CANCER, 1985, 55 (01) : 124 - 135
  • [40] EVIDENCE FOR A HEPATOCELLULAR LINEAGE IN A COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA OF TRANSITIONAL TYPE
    FISCHER, HP
    DOPPL, W
    OSBORN, M
    ALTMANNSBERGER, M
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1988, 56 (02) : 71 - 76